Select Medical SEM
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Select Medical (SEM) Core Market Data and Business Metrics
Latest Closing Price
$16.5Price-Earnings Ratio
9.94Total Outstanding Shares
128.96 Million SharesDividend
$0.06 Per Share QuarterlySIC Description
Services-hospitalsPrimary Exchange
New York Stock ExchangeHeadquarters
C/o Select Medical Corp, Mechanicsburg, PA, 17055
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 1,058,662 Shares | 3.72 | 3/14/2025 | 3,938,989 Shares |
| 1,396,525 Shares | 3.2 | 2/28/2025 | 4,473,241 Shares |
| 740,589 Shares | 5.14 | 2/14/2025 | 3,806,611 Shares |
| 733,993 Shares | 4.9 | 1/31/2025 | 3,594,449 Shares |
| 922,395 Shares | 3.45 | 1/15/2025 | 3,185,407 Shares |
| 1,145,817 Shares | 2.85 | 12/31/2024 | 3,263,534 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Investing Activities | $-231.01 Million |
| Net Cash Flow From Operating Activities, Continuing | $517.86 Million |
| Net Cash Flow From Financing Activities | $-311.17 Million |
| Net Cash Flow From Investing Activities, Continuing | $-231.01 Million |
| Net Cash Flow, Continuing | $-24.31 Million |
| Net Cash Flow From Financing Activities, Continuing | $-311.17 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Income/Loss From Equity Method Investments | $60.23 Million |
| Income Tax Expense/Benefit, Current | $75.65 Million |
| Net Income/Loss Attributable To Redeemable Noncontrolling Interest | $9.40 Million |
| Basic Average Shares | $124.61 Million |
| Income Tax Expense/Benefit | $44.78 Million |
| Income Tax Expense/Benefit, Deferred | $-30.87 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $171.13 Million |
| Other Comprehensive Income/Loss | $-42.91 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $82.67 Million |
| Comprehensive Income/Loss | $253.80 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Equity Attributable To Noncontrolling Interest | $305.57 Million |
| Noncurrent Assets | $4.59 Billion |
| Equity | $1.99 Billion |
| Intangible Assets | $103.18 Million |
| Accounts Payable | $142.16 Million |
| Current Assets | $1.02 Billion |
Historical Dividends
Current dividend: $0.06 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Feb 13, 2025 | Mar 13, 2025 | Mar 3, 2025 | $0.0625 | Quarterly |
| Oct 30, 2024 | Nov 26, 2024 | Nov 13, 2024 | $0.125 | Quarterly |
| Jul 31, 2024 | Aug 30, 2024 | Aug 14, 2024 | $0.125 | Quarterly |
| May 2, 2024 | May 30, 2024 | May 16, 2024 | $0.125 | Quarterly |
| Feb 13, 2024 | Mar 13, 2024 | Mar 1, 2024 | $0.125 | Quarterly |
| Nov 2, 2023 | Nov 28, 2023 | Nov 15, 2023 | $0.125 | Quarterly |